Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma - Concepedia

Concepedia

Publication | Open Access

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

DOI Full Paper Access

21K

Citations

27

References

2005

Year

Roger Stupp, Warren Mason, Martin J. van den Bent, Michael Weller, Barbara Fisher, Martin Taphoorn, Karl Bélanger, Alba A. Brandes, Christine Marosi, Ulrich Bogdahn,

New England Journal of Medicine

Abstract

The addition of temozolomide to radiotherapy for newly diagnosed glioblastoma resulted in a clinically meaningful and statistically significant survival benefit with minimal additional toxicity.

References

	Year	Citations
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma Monika E. Hegi, Annie‐Claire Diserens, Thierry Gorlia, New England Journal of Medicine	2005	7.1K
Response criteria for phase II studies of supratentorial malignant glioma. David R. Macdonald, T L Cascino, S. Clifford Schold, Journal of Clinical Oncology Tumor InnervationOncologic ImagingPet-mriHigh-grade GliomasBrain Lesion	1990	2.4K
Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial Stuart Pocock, Richard Simon Biometrics Prognostic FactorsSequential Treatment AssignmentPatient SelectionRestricted RandomizationPrognosis	1975	2.3K
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents Manel Esteller, Jesús García‐Foncillas, Esther Andion, New England Journal of Medicine	2000	2.2K
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas Michael Walker, Eben Alexander, William E. Hunt, Journal of neurosurgery	1978	1.7K
Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery Michael Walker, Sylvan B. Green, David P. Byar, New England Journal of Medicine	1980	1.6K
Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials W.J. Curran, Charles Scott, John Horton, JNCI Journal of the National Cancer Institute	1993	1.3K
A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Manfred Westphal, Dana Hilt, Enoch Bortey, Neuro-Oncology	2003	1.3K
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson, British Journal of Cancer	2000	932
Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide Roger Stupp, Pierre-Yves Dietrich, Sandrine Ostermann Kraljevic, Journal of Clinical Oncology	2002	812

Page 1